Previous close | 234.33 |
Open | 243.00 |
Bid | 254.77 x 100 |
Ask | 255.21 x 100 |
Day's range | 236.65 - 258.48 |
52-week range | 204.44 - 261.54 |
Volume | |
Avg. volume | 499,663 |
Market cap | 11.32B |
Beta (5Y monthly) | 0.55 |
PE ratio (TTM) | 12.89 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Explore key insights from UTHR's Q1 2024 earnings, featuring a 34% revenue surge and significant strides in product development and shareholder initiatives.
Insightful Analysis of United Therapeutics Corp's Financial Health and Market Position
Q1 2024 United Therapeutics Corp Earnings Call